Homburger advises Siegfried on its acquisition in DiNAMIQS

Siegfried and DiNAQOR entered into an agreement relating to the acquisition by Siegfried of a 95% stake in DiNAQOR DiNAMIQS, a Swiss-based biotechnology company focused on the development and manufacturing of viral vectors for cell and gene therapies. Siegfried will bring DiNAMIQS’ capabilities to commercial scale and establish DiNAMIQS as a best-in-class biotech CDMO for cell and gene therapies. Through this acquisition, Siegfried further expands its footprint in the biologics space and will create significant mid to long-term growth opportunities in a very dynamic market segment.

Homburger acted as counsel to Siegfried. The team included partner Karin Mattle (pictured left) and Oriana Schöni (associate, pictured right; both corporate/m&a), Gregor Bühler and Kristina Martinovic (both IP/IT) as well as Stefan Oesterhelt and Laetitia Fracheboud (both tax). Daniel Hasler (corporate/m&a) advised on the transaction as client relationship partner.